Jul 01, 2026
16 MIN READ

What Should I Expect the First Week of Wegovy? A Detailed Look at Your Initial Journey

Your first week on semaglutide marks the beginning of a personalized weight loss journey. Understanding what to expect—from appetite suppression to mild nausea—helps you navigate this critical early phase with confidence.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jul 01, 2026
16 MIN READ

what should i expect the first week of wegovy? a detailed look at your initial j — PlexusDx GLP-1 education

Last reviewed: July 1, 2026

Last updated: July 1, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

The first seven days of semaglutide therapy set the foundation for your entire treatment experience. Most patients begin on a starting dose designed to allow your body to adapt gradually, with clinical trials showing that early tolerance strongly predicts long-term success. Knowing what to expect during this initial week can help you distinguish normal adjustment responses from true adverse reactions.

Day One: What Happens When You Take Your First Semaglutide Injection

Your first semaglutide injection activates the GLP-1 receptor pathway within minutes to hours, initiating a cascade of signals that affect hunger hormones, gastric emptying, and blood glucose regulation. The starting dose is intentionally modest—typically 0.25 mg—to allow your body to adjust without overwhelming your system. You may feel no immediate changes on day one; semaglutide works gradually, and most noticeable effects emerge over several days rather than hours.

During the first 24 hours, focus on normal eating patterns and stay well hydrated. Your injection site may feel slightly tender or show minimal redness, which typically resolves within hours. Resist the urge to restrict calories aggressively on day one; your appetite suppression will increase naturally as the medication reaches steady-state levels in your bloodstream.

Days Two Through Four: Early Appetite Suppression and Digestive Adjustment

By day two or three, most patients report the first meaningful appetite reduction—a sensation of earlier fullness during meals or reduced cravings between eating periods. This appetite suppression stems from semaglutide's action on the hypothalamus and vagal pathways that regulate hunger. Simultaneously, your stomach's emptying rate slows, which can create a sensation of prolonged fullness even from smaller meal portions.

During this window, mild nausea affects approximately 25–30% of patients starting therapy. This nausea typically remains mild during the starting phase and often improves as your body acclimates over one to two weeks. Eating smaller, protein-rich meals and avoiding greasy or overly sweet foods can minimize digestive discomfort. Some patients also experience mild constipation as gastric motility decreases; staying hydrated and maintaining fiber intake helps address this naturally.

Days Five Through Seven: Stabilization and Appetite Control Pattern Recognition

By the end of your first week, your body begins establishing a new baseline appetite set point. You'll likely notice consistent reduction in hunger signals, reduced portion sizes feeling satisfying, and decreased frequency of between-meal snacking. Energy levels typically remain stable or improve as your body adapts, though some patients report mild fatigue during week one as their metabolic state adjusts.

This final stretch of your first week is ideal for documenting your own response pattern—noting which foods trigger nausea, when your appetite is lowest, and how your satiety has shifted. These observations become valuable data for your PlexusDx clinical team, especially when combined with baseline metabolic markers. Most patients find that by day seven, the initial adjustment phase feels manageable and early appetite benefits feel genuine rather than temporary.

Managing First-Week Side Effects and When to Contact Your Provider

Common first-week experiences include injection-site reactions (minor redness or tenderness), mild nausea, dry mouth, and subtle changes in food preferences. These represent your body's normal adaptation to a new metabolic signal—not signs that semaglutide isn't working. The starting dose (0.25 mg) is specifically chosen to minimize severe side effects while still initiating the therapeutic response.

Contact your provider if you experience severe nausea that prevents adequate hydration or nutrition, signs of injection-site infection (increasing warmth, swelling, or discharge), or symptoms suggesting hypoglycemia (shakiness, sweating, severe dizziness) if you take diabetes medications. PlexusDx supports you through this transition with accessible clinical guidance; your dose may need adjustment in subsequent weeks, but your pricing remains flat—your commitment tier determines your monthly investment, never the dose level.

Optimizing Your First Week: Hydration, Nutrition, and Sleep Strategies

Strategic first-week habits amplify your treatment success. Drink a minimum of 8–10 glasses of water daily, as semaglutide can reduce thirst sensation while your body processes the medication and you consume fewer calories overall. Prioritize protein at every meal—target 20–30 grams per eating occasion—because protein maintains muscle mass, sustains satiety signaling, and moderates nausea by stabilizing blood glucose. Sleep quality also matters: maintain consistent bedtime and wake times, as sleep disruption can blunt appetite-suppressing hormones and slow metabolic adaptation.

Avoid restrictive eating during week one, despite obvious appetite reduction. Your body needs adequate nutrition to process the medication safely and establish sustainable eating patterns. Light exercise—gentle walking or stretching—supports mood and digestion without stressing your system during initial adaptation. Many patients find that structured meal planning (knowing what they'll eat before hunger signals diminish) prevents accidental undereating and ensures balanced nutrition.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Will I feel less hungry immediately, or does semaglutide take several days to work?

Most patients notice subtle appetite reduction by day two or three, with more pronounced fullness and reduced cravings by days four through seven. The starting dose (0.25 mg) produces measurable GLP-1 receptor activation within hours, but the subjective appetite experience typically builds gradually as receptor signaling intensifies and your body's hunger-hormone system recalibrates.

Is nausea during the first week of semaglutide normal, and how long does it last?

Mild nausea affects roughly one in four patients during the starting phase and represents a known, expected side effect as your digestive system adjusts to slower gastric emptying. For most patients, nausea peaks around day two or three and resolves within one to two weeks as tolerance builds. Eating smaller meals, staying hydrated, and avoiding fatty foods can significantly reduce nausea intensity.

What is the starting dose of PlexusDx semaglutide, and will my price change if I increase my dose?

PlexusDx semaglutide injections start at $149 per month, with that pricing holding steady regardless of dose escalation. Your clinical team will increase your dose gradually based on tolerance and response—typically by 0.25 mg weekly over several weeks—but your flat monthly investment remains unchanged. This pricing structure removes the incentive to stay at subtherapeutic doses due to cost concerns.

Can I exercise during my first week on semaglutide, or should I rest?

Light to moderate physical activity during week one is beneficial and safe—think walking, gentle yoga, or swimming. Intense exercise during the initial adjustment phase may amplify nausea or fatigue in some patients. Listen to your body: if you feel energized, light activity supports mood and digestion; if you feel fatigued, rest and allow your system to adapt without additional physical stress.

How does the PlexusDx Precision Peptide Genetic Test help optimize my first-week experience?

The Precision Peptide Genetic Test ($99 add-on after your first month) maps your natural variation in key appetite and weight-regulation genes—including GLP1R, GIPR, FTO, and MC4R pathways. Understanding your genetic predisposition to GLP-1 sensitivity helps PlexusDx predict your likely response timeline and optimize your dose schedule, potentially reducing early side effects and accelerating your therapeutic benefit.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves